Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
about
Acceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors.Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray.Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells.Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo.Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα.Nucleotide-binding oligomerization domain protein 2 deficiency enhances neointimal formation in response to vascular injuryFrequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinomaSpleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis.Reconstruction and signal propagation analysis of the Syk signaling network in breast cancer cells.Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells.Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion.Advances in melanoma senescence and potential clinical application.Glycome and transcriptome regulation of vasculogenesis.Cytokines in osteoblast-conditioned medium promote the migration of breast cancer cells.Involvement of the Syk-mTOR pathway in follicular lymphoma cell invasion and angiogenesis.Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors.Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer cells.Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.Alkyl-capped silicon nanocrystals lack cytotoxicity and have enhanced intracellular accumulation in malignant cells via cholesterol-dependent endocytosis.Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repressionHypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppressionRETRACTED: JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma.Profiling the changes in signaling pathways in ascorbic acid/β-glycerophosphate-induced osteoblastic differentiation
P2860
Q25256591-8D0E9E42-FBE1-4109-89AD-1BDDD65DBBF0Q33205161-191F93D1-91EC-424B-9792-29D7B9DD2080Q33209193-0E710621-D893-47F1-95C6-66EDD91A3C54Q33510688-3DA01E9C-5F9E-40E3-824D-EE3978D6D032Q33725701-62A28FAC-F0D7-4CA4-A21A-D2ED10AA93AAQ34287521-787592FC-50B1-41A7-8AF9-43E4FC001926Q34404016-24B9CB41-547B-4F67-A759-05E8A50A1408Q34534594-E883D796-BFCB-4C15-993B-2FF2222A3383Q35540926-BDB236DD-7496-415B-B47E-7FCEF70E152CQ35699313-0D8AB605-EFF7-4902-B6F5-54867B08B0BDQ36065989-ADC54060-8F4D-416A-8A60-8D5C5A82BA69Q36268287-86EDC17F-3203-40EE-B520-E8AB5C2E941CQ36312079-375DF79F-BF1B-4FE9-94DA-942011FACA80Q37459500-638E7C3F-8E34-44A3-BB6E-697112540316Q37462704-E7738B34-26D1-4DD8-843C-2C85C4E88495Q37818577-596AC92F-A2D3-4C69-846E-1740AC847647Q39000319-F1CF94D4-986C-411E-80E2-9919B51E452FQ39096935-465CF095-0424-4248-8947-AAC347C3BB47Q39472188-DF31788B-C9F8-4614-9685-D2DC444E3A78Q39557228-BE97E9F7-BC54-4770-8A00-B1C2A9AA4BF3Q39586702-DFDDDD11-FC85-4D0E-BB21-42E6BC878FCEQ39887243-A2E850EF-DE20-405E-9639-AD0C5B794B24Q39908510-4A5C8DC0-02FE-462B-82AD-2B039FE58682Q39987047-132928D1-E347-401E-B3AF-276658EB88A5Q40317358-77B29BF1-6812-4A6A-9191-0A9680ECA3CCQ40351474-3C88B841-BF30-45F2-BA4D-DD7819AB15DDQ40448439-2904D8EC-4F5D-45CE-AA52-0D996B1CFAC7Q40536966-7DBA4092-2EEA-42AE-A403-460DCA6DC0CFQ40573463-A003357A-31B9-4093-AF0E-6B106CA158A5Q40603190-901C8A20-1515-4860-98B7-525FA2D976CAQ40627982-520DFEF5-84F6-4EA8-B87F-013342CB13A2Q44456465-B05B64C0-DD98-41ED-8582-D10A4A23D0A1Q45092731-B4F08B2A-968E-44E4-BCB2-2FF534575334Q48161285-19FB4F3B-6713-4B31-B879-9DD5BCEAF351Q57975646-60F2751F-48FF-4179-A89D-4720627E20DB
P2860
Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Syk, a protein-tyrosine kinase ...... tivity in breast cancer cells.
@ast
Syk, a protein-tyrosine kinase ...... tivity in breast cancer cells.
@en
Syk, a protein-tyrosine kinase ...... tivity in breast cancer cells.
@nl
type
label
Syk, a protein-tyrosine kinase ...... tivity in breast cancer cells.
@ast
Syk, a protein-tyrosine kinase ...... tivity in breast cancer cells.
@en
Syk, a protein-tyrosine kinase ...... tivity in breast cancer cells.
@nl
prefLabel
Syk, a protein-tyrosine kinase ...... tivity in breast cancer cells.
@ast
Syk, a protein-tyrosine kinase ...... tivity in breast cancer cells.
@en
Syk, a protein-tyrosine kinase ...... tivity in breast cancer cells.
@nl
P2860
P356
P1476
Syk, a protein-tyrosine kinase ...... tivity in breast cancer cells.
@en
P2093
Ganapati H Mahabeleshwar
P2860
P304
P356
10.1074/JBC.M208905200
P407
P50
P577
2002-12-10T00:00:00Z